検索結果

受付時間 10 時 00 分～18 時 00 分（土、日、祝日を除く） ［報道に関するお問い合わせ先］ 千寿製薬株式会社 広報室 〒541-0048 大阪市中央区瓦町三丁目 1 番 9 号 Mail：cc@senju.co.jp URL：https://www.senju.co.jp 以上

torial disease characterized by an unstable tear film causing discomfort and/or visual impairment, accompanied by ocular surface disorder” *. Recently, the number of DED patients has been increasing d...

benzalkonium chloride (BAC) as a preservative. BAC is widely used in eye drops but it is known to occasionally cause corneal epithelial damage1. Our goal was to develop a formulation that maintains t...

torial disease characterized by an unstable tear film causing discomfort and/or visual impairment, accompanied by ocular surface disorder” *. Recently, the number of DED patients has been increasing d...

n of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; ...